T cell receptor specificity landscape revealed through de novo peptide design
Proceedings of the National Academy of Sciences · 21.10.2025 · 122 (42)
DOI: 10.1073/pnas.2504783122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.10.2025. Verfasst von Gian Marco Visani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA 98195. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Peptides. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | National Institutes of Health (NIH), Gordon and Betty Moore Foundation (GBMF), National Science Foundation (NSF).
Abstract (Originalsprache)
T cells play a key role in adaptive immunity by mounting specific responses against diverse pathogens. Effective bindings between T cell receptors (TCRs) and pathogen derived peptides presented on major histocompatibility complexes (MHCs) mediate immune responses. However, predicting these interactions remains challenging due to limited functional data on T cell reactivities. Here, we introduce a computational approach to predict TCR interactions with peptides presented on MHC-I alleles, and to design immunogenic peptides for specified TCR–MHC complexes. Our method leverages HERMES, a structure-based machine learning model trained on the protein universe to predict amino acid preferences based on local structural environments. Despite no direct training on TCR-pMHC data, HERMES’s implicit physical reasoning enables us to make accurate predictions of both TCR–pMHC binding affinities and T cell activities across diverse viral and cancer epitopes, achieving up to 0.72 correlation with experimental data. Leveraging our TCR recognition model, we develop a computational protocol for de novo design of immunogenic peptides. Through experimental validation in three TCR–MHC systems, we demonstrate that our designs—with up to five substitutions from the native sequence—activate T cells at success rates of up to 50%. Last, we use our generative framework to quantify the diversity of the peptide recognition landscape for various TCR–MHC’s, offering key insights into T cell specificity. Our approach provides a platform for immunogenic peptide and neoantigen design, as well as for evaluating TCR specificity, offering a computational framework to inform design of engineered T cell therapies and vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA 98195.
- Department of Physics, University of Washington, Seattle, WA 98195.
- St. Jude Children's Research Hospital, Memphis, TN 38105.
- Fred Hutchinson Cancer Center, Seattle, WA 98102.
- Department of Applied Mathematics, University of Washington, Seattle, WA 98105.
ORCID-Profile: Gian Marco Visani, Philip Bradley, Paul G Thomas, Armita Nourmohammad
Förderung
- HHS | National Institutes of Health (NIH)
- Gordon and Betty Moore Foundation (GBMF)
- National Science Foundation (NSF)
- UW | Office of Research Central, University of Washington (ORC)
- NIGMS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Visani, G. M., Pun, M. N., Minervina, A. A., Bradley, P., Thomas, P. G., & Nourmohammad, A. (2025). T cell receptor specificity landscape revealed through de novo peptide design. Proceedings of the National Academy of Sciences, 122(42). https://doi.org/10.1073/pnas.2504783122
Vancouver
Visani GM, Pun MN, Minervina AA, Bradley P, Thomas PG, Nourmohammad A. T cell receptor specificity landscape revealed through de novo peptide design. Proceedings of the National Academy of Sciences. 2025;122(42). doi:10.1073/pnas.2504783122
BibTeX
@article{Visani2025,
author = {Visani, Gian Marco and Pun, Michael N and Minervina, Anastasia A and Bradley, Philip and Thomas, Paul G and Nourmohammad, Armita},
title = {T cell receptor specificity landscape revealed through de novo peptide design},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {42},
doi = {10.1073/pnas.2504783122}
}
EUVIMED